Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-013687
Filing Date
2025-02-14
Accepted
2025-02-14 11:23:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5379
  Complete submission text file 0001104659-25-013687.txt   7124
Mailing Address 200 CENTRAL AVENUE ST. PETERSBURG FL 33701
Business Address 200 CENTRAL AVENUE ST. PETERSBURG FL 33701 212-426-7040
ARK Investment Management LLC (Filed by) CIK: 0001697748 (see all company filings)

EIN.: 464309299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Subject) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91542 | Film No.: 25625059
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)